About Us

Accelmed Ventures, part of Accelmed investment house, aims to create successful medical device and digital health companies by using its deep expertise, extensive network and proven track record.

 

Accelmed Ventures positions itself as a leading HealthTech venture fund, investing globally while focusing on:

 

  • Medical Devices and Digital Health companies with exceptional leading teams 

  • Innovative solutions addressing unmet needs in major chronic disease areas such as neurodegenerative, oncology, metabolic and cardiovascular diseases  

  • Companies with a proven clinical concept and/or a proven business model

 

Accelmed Ventures, with its global presence, diverse team background, syndication capabilities with investors worldwide and strong partnerships all over the world with medical centers helps its portfolio companies to thrive. 

We are more than just another fund! 

 

Our team

Dr. Irit Yaniv, MD, MBA

Managing Partner

Irit Yaniv is an experienced and accomplished senior executive in the Medtech industry. Since joining Accelmed, in 2012, she plays a significant role in leading Accelmed’s ventures portfolio companies, serving either as Chairperson or as an active board member.  During these years, she advanced the international network, while expanding the reach of Accelmed companies towards relationship with strategic investors and financial syndication. 


She was the co-founder of two of Accelmed’s portfolio companies in the field of metabolic disorders – e.g. Diabetes and Obesity.
 

Previously, she held operational positions with different medical device companies, including serving as CEO for Metacure and Impulse Dynamics. 

 

She is heavily involved in the Israeli Eco-System, taking an active part in the BioMed, ICI and WHII conferences as well as 8400 project (cohort 2). 

 

Dr. Yaniv holds an MD degree from the Ben-Gurion University and an MBA from the Recanati Business School at Tel Aviv University.

Amir Blatt

Partner

Amir Blatt brings a wide experience in the HealthTech field. He joined Accelmed in 2010 and led or played a pivotal role in the vast majority of its venture and private equity investments including deal structure, syndication and establishing business models. Mr. Blatt serves as a board member on a number of Accelmed companies in the US and Israel.
 

Prior to joining Accelmed, Mr. Blatt worked at Goren Capital Group, a boutique investment bank, advising investors and TA-25 companies on M&A activities and held sales position with Dover Medical Devices, J&J’s diagnostics equipment distributor in Israel at the time. 
 

Mr. Blatt graduated as a biotechnology engineer from the Technion-Israel Institute of Technology in Haifa and holds an MBA from the Recanati School of Management at Tel Aviv University.

Chief Technology Officer

Ilan Ben Oren

Regulatory

Dr. Susan Alpert, PhD, MD

Director of Clinical Affairs

Dr. Ori Ben-Yehuda, MD

Reimbursement

Joel Brill

IP

Dr. Michal Fisher

 

Portfolio

arrow&v
 

News

FDA Grants NEXUS™ Aortic Arch Stent Graft System Breakthrough Designation

April 20, 2020

Endospan is Granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the NEXUS™ Aortic Arch Stent Graft System

Nitiloop's NovaCross Earns FDA Clearance for Treating Chronic Total Occlusion (CTO) Prior to PTCA or Stent Intervention

April 7, 2020

Designed solely for antegrade approach, NovaCross™ is positioned to tap into the $500M CTO market, a market with only few players

Israeli Government to Send Daily Coronavirus-Detection Questionnaire

March 30, 2020

The Health Ministry intends to use the questionnaire to learn which areas are experiencing an increase in the symptoms associated with Covid-19 and gain insight into the spread of the disease

Israeli spacer balloon company BioProtect raises $13m

January 14, 2020

BioProtect's ProSpace balloon spacer protects prostate cancer patients undergoing radiation therapy

 

Contact Us

Azrieli Center, Triangle Building, 45th flr.

132 Menachem Begin Road

Tel Aviv, Israel, 67023

Tel: +972-9-7885599
Email: ventures@accelmed.com

Links

  • White LinkedIn Icon

© 2020 AccelMed Ventures | Site by reut.design